Development and Evaluation of Web-Based Fertility-Related Decision Support for Young Female Cancer Patients
NCT ID: NCT03786458
Last Updated: 2022-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
115 participants
INTERVENTIONAL
2019-01-11
2022-11-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Effectiveness of a Web-based Tool for Fertility Preservation in Cancer Patients
NCT07038174
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
NCT04678414
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
NCT00581646
Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project
NCT06351228
Survival and Reproductive Outcomes of Malignant Ovarian Germ Cell Tumors
NCT05905289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cancer and Fertility Decision making
Cancer and Fertility Decision aid
web-based decision aid
The decision aid is then developed further process of evidence synthesis and multidisciplinary external review.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
web-based decision aid
The decision aid is then developed further process of evidence synthesis and multidisciplinary external review.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have been diagnosed with breast, hematology or ovarian cancer, and will conduct cancer treatment, such as chemotherapy, hormonal or radiation.
* Willing to take questionnaire via computer and tablet.
* Ability to answer the questionnaire with functional emotion and cognition.
* Ability to read newspaper.
* Had been consulted and advised by Doctor on the ability of fertility, but have not decided to give birth to a baby.
Exclusion Criteria
* Had been diagnosed with stage 4 cancer.
* Do not require chemotherapy, hormonal or radiation therapy.
* Not able to read newspaper or do not access the internet.
20 Years
44 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wen-Fang Cheng
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei City, Taipei, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201810014RIND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.